+499.5%
MRNA vs JBHT
+89.9%
+409.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | JBHT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.8% | -5.0% | -2.4% |
| 7D | +5.5% | +4.9% | +0.6% | +5.1% |
| 30D | +158.7% | +0.6% | +158.2% | +158.6% |
| 3M | +182.1% | -3.2% | +185.3% | +183.1% |
| 6M | +151.8% | +17.0% | +134.9% | +139.5% |
| YTD | +393.6% | +41.7% | +351.9% | +359.7% |
| 1Y | +499.5% | +90.0% | +409.5% | +481.0% |
| All | +499.5% | +89.9% | +409.5% | +481.0% |
Cumulative growth
Daily Returns
Daily percentage return beside JBHT.
Daily Out/Under-Performance
Portfolio return minus JBHT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × JBHT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded JBHT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling